Picard Medical shareholders approve reverse stock split and Class B super-voting shares

Picard Medical, Inc.

Reverse stock split approved at ratio 1:15 to 1:50; board to set exact ratio and timing.
Class B common stock created with 20 votes per share; 51.7M for, 4.9M against.
All four director nominees elected: Richard Fang, Sam Van, Joe Xiao, George Ye.
Advisory say-on-pay approved (56.1M for); future votes set to annual frequency.
Ratification of MaloneBailey LLP as independent auditor for 2026 ratified (58.5M for).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.